These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 35104697)

  • 1. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update.
    Desforges AD; Hebert CM; Spence AL; Reid B; Dhaibar HA; Cruz-Topete D; Cornett EM; Kaye AD; Urits I; Viswanath O
    Biomed Pharmacother; 2022 Mar; 147():112671. PubMed ID: 35104697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy.
    Battaglini E; Park SB; Barnes EH; Goldstein D
    Contemp Clin Trials; 2018 Jul; 70():135-138. PubMed ID: 29680317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
    Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
    J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol.
    Jang CE; Jung MS; Sohn EH; Kim M; Yoo HS; Bae K; Kim JR; Lee JS
    Trials; 2018 Sep; 19(1):526. PubMed ID: 30268158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy.
    Avallone A; Bimonte S; Cardone C; Cascella M; Cuomo A
    Anticancer Res; 2022 Oct; 42(10):4667-4678. PubMed ID: 36191965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced peripheral neuropathy: prevention and treatment.
    Pachman DR; Barton DL; Watson JC; Loprinzi CL
    Clin Pharmacol Ther; 2011 Sep; 90(3):377-87. PubMed ID: 21814197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
    Kachrani R; Santana A; Rogala B; Pawasauskas J
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
    Aziz MT; Good BL; Lowe DK
    Ann Pharmacother; 2014 May; 48(5):626-32. PubMed ID: 24577146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of chemotherapy-induced peripheral neuropathy.
    Piccolo J; Kolesar JM
    Am J Health Syst Pharm; 2014 Jan; 71(1):19-25. PubMed ID: 24352178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.
    Hirayama Y; Ishitani K; Sato Y; Iyama S; Takada K; Murase K; Kuroda H; Nagamachi Y; Konuma Y; Fujimi A; Sagawa T; Ono K; Horiguchi H; Terui T; Koike K; Kusakabe T; Sato T; Takimoto R; Kobune M; Kato J
    Int J Clin Oncol; 2015 Oct; 20(5):866-71. PubMed ID: 25762165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management options for established chemotherapy-induced peripheral neuropathy.
    Pachman DR; Watson JC; Lustberg MB; Wagner-Johnston ND; Chan A; Broadfield L; Cheung YT; Steer C; Storey DJ; Chandwani KD; Paice J; Jean-Pierre P; Oh J; Kamath J; Fallon M; Strik H; Koeppen S; Loprinzi CL
    Support Care Cancer; 2014 Aug; 22(8):2281-95. PubMed ID: 24879391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms.
    Hu LY; Mi WL; Wu GC; Wang YQ; Mao-Ying QL
    Curr Neuropharmacol; 2019; 17(2):184-196. PubMed ID: 28925884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review.
    Flatters SJL; Dougherty PM; Colvin LA
    Br J Anaesth; 2017 Oct; 119(4):737-749. PubMed ID: 29121279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy.
    Farshchian N; Alavi A; Heydarheydari S; Moradian N
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):787-793. PubMed ID: 30105459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy.
    Tender T; Rahangdale RR; Balireddy S; Nampoothiri M; Sharma KK; Raghu Chandrashekar H
    Med Oncol; 2021 Apr; 38(5):52. PubMed ID: 33796975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
    Smith EM; Pang H; Ye C; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Le-Lindqwister N; Fadul CE; Loprinzi C; Shapiro CL;
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26603828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.
    Bakogeorgos M; Georgoulias V
    Expert Rev Anticancer Ther; 2017 Nov; 17(11):1045-1060. PubMed ID: 28868935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies for cancer treatment related peripheral neuropathies.
    Pachman DR; Watson JC; Loprinzi CL
    Curr Treat Options Oncol; 2014 Dec; 15(4):567-80. PubMed ID: 25119581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of serotonin-norepinephrine reuptake inhibitors for patients with chemotherapy-induced painful peripheral neuropathy: A meta-analysis.
    Song SY; Ko YB; Kim H; Lee GW; Yang JB; Chang HK; Kwak SM; Jung J; Lee S; Lee SY; Yoo HJ
    Medicine (Baltimore); 2020 Jan; 99(1):e18653. PubMed ID: 31895829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced peripheral neuropathy.
    Fehrenbacher JC
    Prog Mol Biol Transl Sci; 2015; 131():471-508. PubMed ID: 25744683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.